Shanghai MicroPort EP Medtech Co Ltd
SSE:688351
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shanghai MicroPort EP Medtech Co Ltd
SSE:688351
|
CN |
|
Insigma Technology Co Ltd
SSE:600797
|
CN |
|
Zhejiang Yilida Ventilator Co Ltd
SZSE:002686
|
CN |
|
T
|
Tecnoglass Inc
NYSE:TGLS
|
CO |
|
S
|
Shanghai Fudan Forward S&T Co Ltd
SSE:600624
|
CN |
Balance Sheet
Balance Sheet Decomposition
Shanghai MicroPort EP Medtech Co Ltd
Shanghai MicroPort EP Medtech Co Ltd
Balance Sheet
Shanghai MicroPort EP Medtech Co Ltd
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
165
|
446
|
430
|
585
|
266
|
269
|
|
| Cash |
165
|
446
|
427
|
578
|
256
|
269
|
|
| Cash Equivalents |
0
|
0
|
4
|
6
|
10
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
880
|
1 067
|
1 089
|
|
| Total Receivables |
22
|
26
|
27
|
38
|
57
|
88
|
|
| Accounts Receivables |
21
|
25
|
26
|
36
|
55
|
74
|
|
| Other Receivables |
1
|
1
|
1
|
2
|
2
|
14
|
|
| Inventory |
30
|
35
|
45
|
87
|
122
|
128
|
|
| Other Current Assets |
3
|
4
|
6
|
7
|
7
|
3
|
|
| Total Current Assets |
221
|
510
|
508
|
1 596
|
1 519
|
1 578
|
|
| PP&E Net |
46
|
57
|
77
|
100
|
115
|
122
|
|
| PP&E Gross |
46
|
57
|
77
|
100
|
115
|
122
|
|
| Accumulated Depreciation |
15
|
20
|
32
|
45
|
67
|
87
|
|
| Intangible Assets |
30
|
49
|
72
|
86
|
106
|
117
|
|
| Long-Term Investments |
1
|
10
|
7
|
3
|
72
|
69
|
|
| Other Long-Term Assets |
1
|
3
|
4
|
8
|
12
|
8
|
|
| Total Assets |
299
N/A
|
629
+110%
|
669
+6%
|
1 792
+168%
|
1 823
+2%
|
1 894
+4%
|
|
| Liabilities | |||||||
| Accounts Payable |
8
|
5
|
14
|
22
|
37
|
50
|
|
| Accrued Liabilities |
10
|
11
|
16
|
26
|
35
|
29
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
4
|
8
|
9
|
9
|
|
| Other Current Liabilities |
11
|
16
|
13
|
11
|
15
|
20
|
|
| Total Current Liabilities |
29
|
32
|
47
|
66
|
96
|
108
|
|
| Long-Term Debt |
0
|
0
|
9
|
20
|
17
|
8
|
|
| Deferred Income Tax |
0
|
0
|
0
|
4
|
4
|
2
|
|
| Other Liabilities |
21
|
19
|
23
|
26
|
21
|
34
|
|
| Total Liabilities |
51
N/A
|
51
+0%
|
79
+56%
|
117
+48%
|
138
+18%
|
152
+10%
|
|
| Equity | |||||||
| Common Stock |
87
|
400
|
400
|
471
|
471
|
471
|
|
| Retained Earnings |
52
|
46
|
58
|
55
|
49
|
3
|
|
| Additional Paid In Capital |
214
|
225
|
248
|
1 260
|
1 264
|
1 268
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
249
N/A
|
579
+133%
|
590
+2%
|
1 676
+184%
|
1 685
+1%
|
1 742
+3%
|
|
| Total Liabilities & Equity |
299
N/A
|
629
+110%
|
669
+6%
|
1 792
+168%
|
1 823
+2%
|
1 894
+4%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
471
|
471
|
471
|
471
|
471
|
471
|
|